Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
676 JPY | -1.60% | -1.74% | -5.59% |
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.59% | 96.03M | - | ||
+26.77% | 434B | B | ||
+18.99% | 250B | D+ | ||
+12.44% | 144B | A- | ||
+17.31% | 101B | C- | ||
+24.59% | 88.78B | B+ | ||
+57.56% | 58.93B | B- | ||
+15.09% | 46.54B | C+ | ||
+4.39% | 37.25B | B | ||
+20.16% | 35.9B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6095 Stock
- Ratings MedPeer,Inc.